The ABR will offer a dual primary certificate in interventional and diagnostic radiology, representing a shift in expertise, the ABMS announced.
The American Board of Radiology will now offer a dual primary certificate in interventional and diagnostic radiology, representing a shift in imaging expertise. The certificate was recently approved and announced by the American Board of Medical Specialties.
“The range of diseases to which interventional methods are applied, the responsibility of the practitioner to provide peri-procedural care in both inpatient and outpatient settings, the technical complexity of the interventions and the range of imaging methods used for procedures have all grown significantly in the past two decades,” Gary J. Becker, MD, ABR executive director, said in a statement announcing the training and certification.
Physicians who become board certified in interventional radiology/diagnostic radiology will have:
• Competency in diagnostic imaging to ensure the appropriate, safe and efficacious guidance of current interventional procedures for a wide variety of patients
• Competency in the technical aspects of interventional procedures
• The clinical judgment and skills to participate as team members in the peri-procedural care of patients undergoing interventional radiological procedures
New Study Examines Short-Term Consistency of Large Language Models in Radiology
November 22nd 2024While GPT-4 demonstrated higher overall accuracy than other large language models in answering ACR Diagnostic in Training Exam multiple-choice questions, researchers noted an eight percent decrease in GPT-4’s accuracy rate from the first month to the third month of the study.
FDA Grants Expanded 510(k) Clearance for Xenoview 3T MRI Chest Coil in GE HealthCare MRI Platforms
November 21st 2024Utilized in conjunction with hyperpolarized Xenon-129 for the assessment of lung ventilation, the chest coil can now be employed in the Signa Premier and Discovery MR750 3T MRI systems.
FDA Clears AI-Powered Ultrasound Software for Cardiac Amyloidosis Detection
November 20th 2024The AI-enabled EchoGo® Amyloidosis software for echocardiography has reportedly demonstrated an 84.5 percent sensitivity rate for diagnosing cardiac amyloidosis in heart failure patients 65 years of age and older.